Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death.
Although the burden of alcohol-and NASH-related HCC is growing, chronic viral hepatitis …

Simple Summary Hepatocellular carcinoma (HCC) is the most frequent primitive cancer of
the liver, accounting for 90% of all recorded cases. HCC is the third most common cause of …

Background IMbrave150 has established the superiority of atezolizumab plus bevacizumab
over sorafenib in patients with unresectable hepatocellular carcinoma (HCC). Methods We …

Simple Summary The investigation of predictive and prognostic markers is pivotal in patients
affected by hepatocellular carcinoma treated with immune-checkpoint-inhibitors …

Aim: We investigated the efficacy and safety of hepatic artery infusion chemotherapy (HAIC)
combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors (TKIs) for advanced …

Abstract Background and Aims Different approaches are available after the progression of
disease (PD) to immune checkpoint inhibitors (ICIs) for hepatocellular carcinoma (HCC) …

Hepatocellular carcinoma (HCC) represents the most common primary liver cancer and is
considered a major global health problem as one of the leading causes of cancer-related …

Primary liver cancer is the second leading cause of tumor-related deaths in China, with
hepatocellular carcinoma (HCC) accounting for 80%–90% of these. Since there is a lack of …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and shows
high global incidence and mortality rates. The liver is an immune-tolerated organ with a …

Six Gasdermins (GSDM) family members participate in various biological processes
especially pyroptosis, as well as in the initiation and development of many types of cancer …